NATAC
NAT | BME Growth
Overview
Corporate Details
- ISIN(s):
- ES0171613005
- LEI:
- 959800CAJAU3LNQW9246
- Country:
- Spain
- Address:
- AVA RITA LEVI MONTALCINI 14, 28906 Getafe
- Website:
- https://natacgroup.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
NATAC specializes in the production of natural ingredients and health solutions for the pharmaceutical sector.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Molecular Partners AG | Switzerland | MOLN | |
|
MorphoSys AG | Germany | MOR | |
|
MPH Health Care | Germany | 93M1 | |
|
Navamedic | Norway | NAVA | |
|
Newbury Pharmaceuticals AB | Sweden | NEWBRY | |
|
New Nordic Healthbrands AB | Sweden | NNH | |
|
Nicoccino Holding AB | Sweden | NICO | |
|
Nicox S.A. | France | COX | |
|
Novartis AG | Switzerland | NOVN | |
|
Nur Ink Innovations Ltd. | Israel | NURI |